Results 91 to 100 of about 1,042,654 (268)

Mobile genetic elements in Clostridium difficile and their role in genome function. [PDF]

open access: yes, 2015
Approximately 11% the Clostridium difficile genome is made up of mobile genetic elements which have a profound effect on the biology of the organism. This includes transfer of antibiotic resistance and other factors that allow the organism to survive ...
Roberts, AP, Mullany, P, Allan, E
core  

Low Incidence of Hospital-Onset Clostridium difficile Infection in Sickle Cell Disease

open access: yes, 2019
Anemia, Sickle Cell, Clostridium Infections, Clostridium ...
Batool, Saleha   +5 more
core   +1 more source

The gut microbiome and drug‐resistant epilepsy: Microbiome–antiseizure medication interactions and implications for pharmacoresistance

open access: yesEpilepsia Open, EarlyView.
Abstract Drug‐resistant epilepsy (DRE) affects approximately one‐third of patients with epilepsy and represents a major unmet clinical need. While traditional hypotheses of pharmacoresistance have focused on alterations in drug targets, efflux transporter overexpression, and intrinsic disease severity, the gut microbiome has recently emerged as a ...
Khaled Zammar   +4 more
wiley   +1 more source

Demographics and medical histories of Clostridium difficile infections with ribotypes 017 (R017) and 018 (R018)

open access: yes, 2016
Demographics and medical histories of Clostridium difficile infections with ribotypes 017 (R017) and 018 (R018)
Jieun Kim (427023)   +2 more
core   +1 more source

Diagnosis of bacteraemia in neonatal foals using 16S rRNA high‐throughput sequencing

open access: yesEquine Veterinary Journal, EarlyView.
Abstract Background Sepsis is an important cause of morbidity and mortality in foals. Early diagnosis can improve outcome but is complicated by non‐specific clinical signs and delayed confirmation of infection via blood culture. Molecular assays represent a rapid and more sensitive alternative.
Flavie Payette   +7 more
wiley   +1 more source

Clinical characteristics and treatment outcomes of Clostridium difficile infections with ribotypes 017 (R017) and 018 (R018)

open access: yes, 2016
Clinical characteristics and treatment outcomes of Clostridium difficile infections with ribotypes 017 (R017) and 018 (R018)
Jieun Kim (427023)   +2 more
core   +1 more source

Antibody kinetics against tetanus toxoid before and after primary vaccination of foals

open access: yesEquine Veterinary Journal, EarlyView.
Abstract Background Vaccination recommendations for foals against Clostridium tetani vary. Available studies assessing foal immune responses, maternal antibody interference, or individual variation often used small foal numbers. Objectives To quantify antibody responses after tetanus vaccination in foals and explore associations with passively ...
Katharina Olbrich   +2 more
wiley   +1 more source

Foot Infection by Clostridium sordellii: Case Report and Review of 15 Cases in France

open access: yes, 2015
International audienceWe report a case of foot infection by Clostridium sordellii and review 15 human infections registered at a Reference Center in France during the period 1998 to 2011. All strains were found nontoxigenic, lacking the lethal toxin gene
Mory, Francine   +5 more
core   +1 more source

Comprehensive Review on Advancements in Food Preservation Technologies for Quality and Sustainability

open access: yesFood Chemistry International, EarlyView.
Preservatives limit microbial development, oxidation, and enzymatic degradation, resulting in better food quality and extended shelf life. Classified as natural, synthetic, or biological, each preservative has distinctive attributes and modes of action. Growing preference for natural preservatives aligns with clean label trends.
Monica Suresh   +4 more
wiley   +1 more source

Evaluating Epidemiology and Improving Surveillance of Infections Associated with Health Care, United States

open access: yesEmerging Infectious Diseases, 2015
The Healthcare-Associated Infections Community Interface (HAIC), launched in 2009, is the newest major activity of the Emerging Infections Program.
Shelley S. Magill   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy